← back to search

Sandra D. Scherer

University of Utah · US
Area of research
Oncology · Cancer Research
Research interest
Research interests include Cancer Cells and Metastasis, Cancer Genomics and Diagnostics, 3D Printing in Biomedical Research, and RNA Research and Splicing.
h-index
17
citations
1,625
works
57
NIH funding
primary concept
email

Recent publications

Patient-Derived Models of Cancer in the NCI PDMC Consortium: Selection, Pitfalls, and Practical Recommendations
Cancers 2024cited by 6position: middledoi
Transferred mitochondria accumulate reactive oxygen species, promoting proliferation
eLife 2023cited by 90position: middledoi
Breast cancer PDxO cultures for drug discovery and functional precision oncology
STAR Protocols 2023cited by 16position: firstdoi
A human breast cancer-derived xenograft and organoid platform for drug discovery and precision oncology
Nature Cancer 2022cited by 387position: middledoi
Multiparametric quantitative phase imaging for real-time, single cell, drug screening in breast cancer
Communications Biology 2022cited by 52position: middledoi
Conservation of copy number profiles during engraftment and passaging of patient-derived cancer xenografts
Nature Genetics 2021cited by 190position: middledoi
Comprehensive characterization of 536 patient-derived xenograft models prioritizes candidates for targeted treatment
Nature Communications 2021cited by 108position: middledoi
An immune-humanized patient-derived xenograft model of estrogen-independent, hormone receptor positive metastatic breast cancer
Breast Cancer Research 2021cited by 40position: firstdoi
IER2-induced senescence drives melanoma invasion through osteopontin
Oncogene 2021cited by 36position: middledoi
CD229 CAR T cells eliminate multiple myeloma and tumor propagating cells without fratricide
Nature Communications 2020cited by 78position: middledoi
ETV4 Is Necessary for Estrogen Signaling and Growth in Endometrial Cancer Cells
Cancer Research 2020cited by 71position: middledoi
Macrophage-Induced Lymphangiogenesis and Metastasis following Paclitaxel Chemotherapy Is Regulated by VEGFR3
Cell Reports 2016cited by 118position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Alana L. Welm · University of Utah4 papers (2020–2023)Bryan E. Welm · University of Utah3 papers (2020–2023)Jonathan P. Sleeman · Karlsruhe Institute of Technology2 papers (2016–2021)Andrew Butterfield · Trinity College Dublin2 papers (2022–2023)Ling Zhao · Tarim University2 papers (2021–2023)Chieh‐Hsiang Yang · University of Utah2 papers (2020–2023)Emilio Cortes-Sanchez · University of Utah2 papers (2022–2023)Thomas A. Zangle · University of Utah2 papers (2022–2023)Katrin P. Guillen · University of Utah2 papers (2020–2023)Tim Luetkens · University of Maryland, Baltimore1 papers (2020–2020) · 1 papers (2016–2016)Neta Ilan · Hebrew University of Jerusalem1 papers (2016–2016)Giorgia Foggetti · Yale Cancer Center1 papers (2024–2024)Kathleen A. Clark · University of Utah1 papers (2020–2020)Maihi Fujita · University of Utah1 papers (2021–2021)Kerstin Rönsch · University Hospital Heidelberg1 papers (2021–2021)Estefanía Labanca · Roswell Park Comprehensive Cancer Center1 papers (2024–2024) · 1 papers (2016–2016)Jared Rutter · University of Utah1 papers (2023–2023)William F. Flynn · Jackson Laboratory1 papers (2024–2024)